What is dosist?
Established in 2016 and headquartered in Santa Monica, California, dosist operates as a contemporary wellness enterprise. The company's core mission is to empower individuals to naturally manage their health and happiness through precisely controlled cannabis therapy. dosist distinguishes itself by offering innovative solutions that provide a reliable and effective approach to wellness, leveraging the therapeutic potential of cannabis in a regulated and accessible manner.
How much funding has dosist raised?
dosist has raised a total of $15M across 1 funding round:
Private Equity
$15M
Private Equity (2020): $15M with participation from Turning Point Brands, Inc.
Key Investors in dosist
Turning Point Brands, Inc.
Turning Point Brands, Inc. is a significant player in the consumer products industry, with a focus on tobacco and related accessories. Their investment in dosist suggests a strategic interest in the burgeoning cannabis wellness market and potential synergies within the broader adult-use consumer goods sector.
What's next for dosist?
With a substantial enterprise-level funding context, dosist is strategically positioned for significant scaling and market expansion. The recent major strategic investment signals strong confidence from backers in the company's business model and its potential for future growth. This backing will likely fuel advancements in product development, broader market penetration, and potentially new therapeutic applications. The company's focus on dose-controlled therapy suggests a trajectory towards becoming a leader in the regulated cannabis wellness sector, aiming to further integrate its offerings into mainstream health and happiness management.
See full dosist company page